Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

AGRX Agile Therapeutics Inc

0,6022

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

0001104659-24-011653.txt

Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Agile Therapeutics Charts.

Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Agile Therapeutics Charts.

News Agile Therapeutics Inc

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Donnerstag 28 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Agile Therapeutics Announces Delisting from Nasdaq
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Mittwoch 20 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Mittwoch 13 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 23 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 23 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
Donnerstag 22 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
Donnerstag 15 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mittwoch 7 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Agile Therapeutics Inc News-Artikel

Deutsche Telekom (QX)

BNP Paribas (QX)

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen